Skip to main content
SpringerLink
Log in

Afatinib/bevacizumab

Diarrhoea, jaw osteonecrosis and cutaneous ulcer: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ninomiya T, et al. Survival of chemo-naive patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404. Japanese Journal of Clinical Oncology 51: 1269-1276, No. 8, Aug 2021. Available from: URL: http://doi.org/10.1093/jjco/hyab084

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Afatinib/bevacizumab. Reactions Weekly 1884, 26 (2021). https://doi.org/10.1007/s40278-021-06347-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-06347-7

Search

Navigation